Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Rilonacept bulk supplier for pharma manufacturers

Rilonacept 220mg/vial Suppliers & Bulk Manufacturers

Available Forms: injection

Available Strengths: 220mg/vial

Reference Brands: Arcalyst (USA/EU)

Category: Immune Disorder

Rilonacept (Arcalyst) is a subcutaneous IL-1 inhibitor used to treat Cryopyrin-Associated Periodic Syndromes (CAPS), including Familial Cold Autoinflammatory Syndrome (FCAS) and Muckle-Wells Syndrome (MWS). It works by blocking interleukin-1, a protein that drives inflammation in these rare auto-inflammatory disorders. Rilonacept is available as an 80 mg/mL solution in pre-filled syringes.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Rilonacept — third party manufacturing & bulk supply

Rilonacept 220mg/vial is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Rilonacept is supplied as injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Rilonacept listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Rilonacept →
Back to Listing

Frequently Asked Questions

Rilonacept is listed as injection in 220mg/vial. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Rilonacept is referenced against Arcalyst (USA/EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.

Related Products

Etrasimod Arginine

Strength:
2 mg, 4 mg, 6 mg

Form: Tablets

Reference Brands: Velsipity (USA)

View Details
Avacopan

Strength:
10 mg

Form: Capsules

Reference Brands: Tavneos (USA/EU)

View Details
Fostamatinib Disodium

Strength:
100 mg, 150 mg

Form: Tablets

Reference Brands: Tavalisse (USA)

View Details
Deucravacitinib

Strength:
6 mg

Form: Tablet

Reference Brands: Sotyktu (USA/EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.